4.5 Article

Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016)

Journal

EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 27, Issue 9, Pages 1031-1045

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/13543776.2017.1338687

Keywords

Benzopyran derivatives; inhibitors; anti-inflammatiory; anticancer; anti-arthritis; antibacterial; anti-Alzheimer activities; anti-skin diseases activities; antiviral; treatment type 2 diabetes and ADPKD

Funding

  1. National Natural Science Foundation of China [21572003, 21272008]
  2. Natural Science Foundation of Anhui Province [1508085QH195]

Ask authors/readers for more resources

Introduction: The benzopyran derivatives present a wide variety of biological activity and behaviour. At the same time the benzopyran derivatives support their use as therapeutic agents for multiple diseases. Their structural characteristics correlated to physicochemical properties seem to define the extent of the biological activity. Areas covered: This review summarizes new patents published on new benzopyran derivatives from 2009 to 2016. Expert opinion: Many benzopyran derivatives have vivo/vitro biological responses. Their clinical evaluation will be critical to assess therapeutic utility. The compounds containing benzopyran moiety is well defined as lead compounds for design of new more promising molecules.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available